StockData

Establishment Labs vs InMode

ESTA and INMD side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ESTA and INMD compare

Establishment Labs grew revenue faster over the last twelve months (38.3% versus −6.2% for InMode).

InMode scores higher on the StockData Score (6 against 5 for Establishment Labs), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricESTAINMD
Size and price
Market cap$2.1B–
Share price$70.75$13.27
Change, 1 year12.0%−9.2%
Change, 5 years9.7%−85.0%
Beta (5Y)1.181.43
Employees1,004660
StockData Score
Total score56 (better)
Valuation score00
Growth score3 (better)0
Performance score11
Health score15 (better)
Dividend score00
Valuation
P/S8.0×–
P/B135×–
FCF yield−1.0%–
Growth
Revenue growth (TTM)38.3% (better)−6.2%
Revenue growth, 5Y average20.0% (better)12.4%
EPS growth (TTM)–−36.4%
EPS growth, 5Y average–9.9%
Profitability
Gross margin70.2%78.5% (better)
Operating margin−6.6%23.0% (better)
Net margin−14.6%–
FCF margin−8.2%22.7% (better)
Return on equity−241%–
Return on invested capital−6.7%25.1% (better)
Financial health
Debt / equity17.17 (better)0.00
Interest coverage−0.6×–
Current ratio3.579.88 (better)
Altman Z-score2.80–
Piotroski F-score3–
Dividends and buybacks
Shareholder yield0.00%–
Ownership
Held by institutions95.8%49.5%
Held by insiders9.6%12.0%
Insider net buying, 12 months−$35.5M–
Short interest, % of float14.6%4.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.